BRIEF-Microbix Biosystems says consulted with FDA to return its thrombolytic biologic drug to U.S. market

* Microbix Biosystems Inc - consulted with FDA regarding plans to return its thrombolytic biologic drug, kinlytic urokinase to U.S. market